Resultados de la búsqueda 131-140 of 12583 for HIV infection

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

2. Hematología - Ensayos clínicos - Mayo Clinic

   The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used. Fertility outcomes in ...

5. Cirugía - Ensayos clínicos - Mayo Clinic

   Multi-Center Prospective Validation Study of VTE Risk Prediction Tool in Trauma Patients. Rochester, Minn. Almost one-half million people suffer venous ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. To evaluate the clinical outcomes related to IIC, including the ...

7. Eligibility and FAQs - Mayo Clinic

   ... infection such as hepatitis B, hepatitis C or HIV. All donated blood is tested for certain infections. But these tests are not the same tests used to ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.

9. Cirugía - Ensayos clínicos - Mayo Clinic

   To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...